Tscan Therapeutics Inc (TCRX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
23,044,900
EV to revenue ratio (TTM)
2.168
EV to ebitda
0.392
Financial Performance
Revenue (TTM)
7,111,000
Gross profit (TTM)
-88,323,000
EBITDA
-115,660,000
Profitability
Operating margin (TTM)
-2,901.00%
Profit margin
0.00%
Return on assets (TTM)
-31.50%
Return on equity (TTM)
-95.80%
Per Share Metrics
Revenue per share (TTM)
0.11
EPS
-0.9
Diluted EPS (TTM)
-0.9
Book value
1.02
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
3.241
Price to book ratio (TTM)
0.358
Growth
Quarterly earnings growth (YoY)
-65.80%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
4
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.069